百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供_老虎社区_美港股上老虎

百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供

每日经济新闻2022-01-19

有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

不靠谱的包子
·2022-01-19
江湖传闻，你家去太阳系的火箭有我提供的组份，问，什么组份？？里边那个小板凳是我提供的[笑哭] [笑哭] [笑哭] [笑哭] [笑哭]
回复
点赞
举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://ttm.financial/m/news/2204031834?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","is_english":false,"pubTime":"2022-01-19 14:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2204031834","market":"us","top_or_hot":-1,"title":"百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供","media":"每日经济新闻","content":"<div>\n<p>有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 14:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"301080","symbol_name":"百普赛斯","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b","article_id":"2204031834","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2204031834","pubTimestamp":1642572960,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"301080":"百普赛斯","BK4568":"美国抗疫概念","BK4007":"制药","BK4516":"特朗普概念","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","PFE":"辉瑞","MRK":"默沙东","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4559":"巴菲特持仓"},"translate_title":"Pepseth: The related components of Pfizer and Merck COVID-19 oral antiviral drugs are not provided by the company","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"301080":1,"MRK":1,"PFE":1},"content_text":"有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"},"commentList":[{"id":697787361,"gmtCreate":1642594819204,"gmtModify":1642594819204,"author":{"id":"3549750168440330","authorId":"3549750168440330","name":"不靠谱的包子","avatar":"https://static.tigerbbs.com/17b6f471c8ae7de275b6c6143f73ef5e","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3549750168440330","authorIdStr":"3549750168440330"},"htmlText":"江湖传闻，你家去太阳系的火箭有我提供的组份，问，什么组份？？里边那个小板凳是我提供的[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;","listText":"江湖传闻，你家去太阳系的火箭有我提供的组份，问，什么组份？？里边那个小板凳是我提供的[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;[笑哭]&nbsp;","text":"江湖传闻，你家去太阳系的火箭有我提供的组份，问，什么组份？？里边那个小板凳是我提供的[笑哭] [笑哭] [笑哭] [笑哭] [笑哭]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/697787361","repostId":2204031834,"repostType":2,"repost":{"id":"2204031834","kind":"news","pubTimestamp":1642572960,"share":"https://ttm.financial/m/news/2204031834?lang=&edition=full","pubTime":"2022-01-19 14:16","market":"us","language":"zh","title":"百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供","url":"https://stock-news.laohu8.com/highlight/detail?id=2204031834","media":"每日经济新闻","summary":"有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）","content":"<div>\n<p>有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b\">Web Link</a>\n\n</div>\n","source":"tencent","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n百普赛斯：辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-19 14:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b><strong>每日经济新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/8063c97727cb21de0867e6829ff807e3","relate_stocks":{"301080":"百普赛斯","BK4568":"美国抗疫概念","BK4007":"制药","BK4516":"特朗普概念","BK4550":"红杉资本持仓","BK4534":"瑞士信贷持仓","PFE":"辉瑞","MRK":"默沙东","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4559":"巴菲特持仓"},"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202201191421537c6ca9a0&s=b","is_english":false,"share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","article_id":"2204031834","content_text":"有投资者在投资者互动平台提问：请问新冠特效药、疫苗生产公司辉瑞、默沙东，吉利德与公司有合作吗？百普赛斯(301080.SZ)1月19日在投资者互动平台表示，辉瑞、默沙东新冠口服抗病毒药物的相关组分非公司提供。公司开发的重组蛋白、抗体和试剂盒等产品可以用于新冠病毒科学研究、疫苗研发、抗体药物和小分子药物的研发等用途。（文章来源：每日经济新闻）","news_type":1,"symbols_score_info":{"301080":1,"MRK":1,"PFE":1}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}